{
 "as_of": "2026-11-06",
 "cmr": "ca-cm-kg/TSXV/NTLX",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# NeuroThera Labs Inc. (TSXV: NTLX) — research page\n\nAs of 2026-11-06 · ca-cm-kg · record version 1\n\n## Identity and listing\n\nNeuroThera Labs Inc. is listed on the TSXV under ticker NTLX. The ISIN is not on the record; the LEI is 529900GPL3C0DVADMS32. The security type is Corporate, the sector is Life Sciences, and the jurisdiction is British Columbia (CA-BC). The segment is not on the record. The listing status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 23 filings in the twelve months to 2026-11-06, across 20 filing days. Of these, 20 are newswire releases, 2 are exchange bulletins and 1 is a corporate action. The median gap between filing days is 13 days, against a TSXV median of 19 days and a Life Sciences median of 17.5 days. Days from the latest filing to the record date are 15, against a TSXV median of 17.0 days and a Life Sciences median of 14 days. The latest filing is a newswire release dated 2026-10-22. The TSXV median filings count is 9 and the Life Sciences median is 7.0.\n\n## Auditor\n\nThe auditor is not on the record; none was found. The auditor's location is not on the record, and the record holds no auditor changes.\n\n## Events and halts\n\nThe record holds two name changes, dated 2025-10-23 and 2026-08-31. It holds no listing, delisting, domicile change or segment move lines. The halt flag is listed, not halted.\n\n## Orderability\n\nUnder the acm-68000/ca/kyp-know-your-product-ni-31-103/r1 rule version, the outcome is determinable for both client categories: paragraph (o) of the definition and paragraph (q) of the definition, each with signal ACM-200. The chapter is as of 2026-11-04.\n\n## Coverage\n\nNo research houses were found on the issuer's investor-relations pages read; the count is 0.\n\n## Open research\n\nNo openly published research notes were found; the count is 0.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe vintage is not sealed, and no issuer years are sealed. The market's earliest sealed date is not on the record. The live record began on 2026-09-10. Years 2021 through 2026 are sealed in the store but are not served as of a date; the as-of door answers not_sealed.\n\n## Sources\n\n7 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://www.tsx.com/json/company-directory/search/tsxv/^* (identity.exchange)\n- https://api.gleif.org/api/v1/lei-records/529900GPL3C0DVADMS32 (identity.jurisdiction)\n- https://www.tsx.com/en/resource/571 (identity.sector)\n- https://mcp.ca-cm-kg.ai/events/TSXV/NTLX (the disclosure lines)\n- https://iiroc.mediaroom.com/index.php?s=2429&l=100 (the halt flag)\n- https://mcp.ca-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://mcp.ca-cm-kg.ai/record/TSXV/NTLX (the record)\n",
 "market": "CA",
 "node": "ca-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [],
   "live_record_began": "2026-09-10",
   "node_history_from": null,
   "node_years_sealed": [],
   "note": "6 years are sealed in the CA store; their Replay split is not built, so the as-of door answers not_sealed and the record is the live record as of 2026-11-06",
   "record_version": 1,
   "sealed": false,
   "store_years_sealed_not_served": [
    "2021",
    "2022",
    "2023",
    "2024",
    "2025",
    "2026"
   ]
  },
  "auditor": {
   "auditor": {
    "market": "CA",
    "reason": "none found",
    "state": "not_on_record"
   },
   "auditor_firm_id": {
    "market": "CA",
    "state": "not_on_record"
   },
   "auditor_location": {
    "market": "CA",
    "state": "not_on_record"
   },
   "changes": []
  },
  "cmr": "ca-cm-kg/TSXV/NTLX",
  "coverage": {
   "count": 0,
   "houses": [],
   "pages_checked": [],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-12",
   "since": null,
   "state": "none_found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 1427,
     "median_cadence_gap_days": 19,
     "median_filings": 9,
     "median_latency_days": 17,
     "name": "TSXV"
    },
    "sector": {
     "issuers": 200,
     "median_cadence_gap_days": 17.5,
     "median_filings": 7,
     "median_latency_days": 14,
     "name": "Life Sciences"
    }
   },
   "by_type": {
    "corporate_action": 1,
    "exchange_bulletin": 2,
    "newswire_release": 20
   },
   "cadence_median_gap_days": 13,
   "filing_days": 20,
   "filings": 23,
   "latency_days": 15,
   "latest": [
    {
     "category": null,
     "date": "2026-10-22",
     "source": "https://www.thenewswire.com/press-releases/1BKRFazqD-neurothera-labs-reports-positive-progress-in-fda-approved-phase-iib-clinical-trial-for-tourette-syndrome.html",
     "title": "NeuroThera Labs Reports Positive Progress in FDA ...",
     "type": "newswire_release"
    },
    {
     "category": null,
     "date": "2026-10-22",
     "source": "https://www.globenewswire.com/news-release/2026/10/22/3386394/0/en/scisparc-subsidiary-neurothera-labs-reports-positive-progress-in-fda-approved-phase-iib-clinical-trial-for-tourette-syndrome.html",
     "title": "SciSparc: Subsidiary NeuroThera Labs Reports Positive",
     "type": "newswire_release"
    },
    {
     "category": null,
     "date": "2026-10-07",
     "source": "https://www.globenewswire.com/news-release/2026/10/07/3376445/0/en/scisparc-subsidiary-neurothera-labs-cliniquantum-reports-successful-quantum-enabled-analysis-of-billions-of-gene-combinations-using-real-world-clinical-data-on-an-s-p-500-company-s.html",
     "title": "SciSparc: Subsidiary NeuroThera Labs’ CliniQuantum Reports",
     "type": "newswire_release"
    },
    {
     "category": null,
     "date": "2026-09-23",
     "source": "https://www.globenewswire.com/news-release/2026/09/23/3367467/0/en/scisparc-subsidiary-neurothera-highlights-enhancement-of-u-s-patent-portfolio-through-collaboration-with-clearmind-covering-lsd-ketamine-and-ibogaine-combinations.html",
     "title": "SciSparc: Subsidiary NeuroThera Highlights Enhancement of",
     "type": "newswire_release"
    },
    {
     "category": null,
     "date": "2026-09-02",
     "source": "https://www.globenewswire.com/news-release/2026/09/02/3355122/0/en/scisparc-subsidiary-neurothera-labs-pursues-fda-orphan-drug-designation-for-adult-tourette-syndrome-drug-engages-government-and-public-affairs-firm-rk-strategies.html",
     "title": "SciSparc: Subsidiary NeuroThera Labs Pursues FDA Orphan Drug Designation For Adult Tourette Syndrome Drug; Engages Government and Public Affairs Firm RK Strategies",
     "type": "newswire_release"
    }
   ],
   "latest_filing_date": "2026-10-22",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.ca-cm-kg.ai/events/TSXV/NTLX",
   "window": {
    "from": "2025-11-06",
    "to": "2026-11-06"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "tsx.com company directory (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.tsx.com/json/company-directory/search/tsxv/^*",
    "state": "sourced",
    "value": "TSXV"
   },
   "isin": {
    "market": "CA",
    "reason": "no ISIN found on issuer pages",
    "state": "not_on_record"
   },
   "jurisdiction": {
    "read_by": "GLEIF LEI record (LEI per the LEI column)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://api.gleif.org/api/v1/lei-records/529900GPL3C0DVADMS32",
    "state": "confirmed",
    "value": "British Columbia (CA-BC)"
   },
   "lei": {
    "read_by": "GLEIF name-exact",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://api.gleif.org/api/v1/lei-records/529900GPL3C0DVADMS32",
    "state": "sourced",
    "value": "529900GPL3C0DVADMS32"
   },
   "name": {
    "read_by": "tsx.com company directory (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.tsx.com/json/company-directory/search/tsxv/^*",
    "state": "sourced",
    "value": "NeuroThera Labs Inc."
   },
   "sector": {
    "read_by": "TMX listed-companies workbook (exchange list, monthly; data month named in the source column)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.tsx.com/en/resource/571 (tsx-and-amp-tsxv-listed-companies-2026-08-14-en.xlsx, data as of 31-Jul-2026)",
    "state": "sourced",
    "value": "Life Sciences"
   },
   "security_type": {
    "read_by": "TMX listed-companies workbook (exchange list, monthly; data month named in the source column)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.tsx.com/en/resource/571 (tsx-and-amp-tsxv-listed-companies-2026-08-14-en.xlsx, data as of 31-Jul-2026)",
    "state": "sourced",
    "value": "Corporate"
   },
   "segment": {
    "market": "CA",
    "state": "not_on_record"
   },
   "ticker": {
    "read_by": "tsx.com company directory (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.tsx.com/json/company-directory/search/tsxv/^*",
    "state": "sourced",
    "value": "NTLX"
   },
   "website": {
    "market": "CA",
    "state": "not_on_record"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": [],
   "domicile_change": [],
   "listing": [],
   "name_change": [
    {
     "date": "2025-10-23",
     "source": "http://apps.tmx.com/TSXVenture/TSXVentureHttpController?GetPage=NoticesContents&PO_ID=&NOTICE_ID=304907&CORRECTION_FLG=N&HC_FLAG1=checked",
     "title": "TSXV bulletin: NAME CHANGE (Constating Documents)"
    },
    {
     "date": "2026-08-31",
     "source": "http://apps.tmx.com/TSXVenture/TSXVentureHttpController?GetPage=NoticesContents&PO_ID=&NOTICE_ID=321000&CORRECTION_FLG=N&HC_FLAG1=checked",
     "title": "TSXV bulletin: CONSOLIDATION WITHOUT A NAME CHANGE (Constating Documents)"
    }
   ],
   "segment_move": []
  },
  "market": "CA",
  "node": "ca-cm-kg",
  "numbers_hash": "sha256:e2daa5d6f3c68554d2eb42f97de788c4de3d6c05ff2f063cf7ca49048816677b",
  "open_research": {
   "read_date": "2026-11-12",
   "rows": [],
   "state": "none_found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [
    "Paragraph (o) of the definition",
    "Paragraph (q) of the definition"
   ],
   "outcomes": {
    "Paragraph (o) of the definition": {
     "determinable": true,
     "signal": "ACM-200"
    },
    "Paragraph (q) of the definition": {
     "determinable": true,
     "signal": "ACM-200"
    }
   },
   "read": {
    "basis": "one live read per instrument class, halt state and client category on this market; this issuer's group",
    "chapter": "https://mcp.ca-cm-kg.ai/book/aio.json",
    "door": "https://mcp.ca-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "rule_version": "acm-68000/ca/kyp-know-your-product-ni-31-103/r1",
   "section": "ca.aio.v11"
  },
  "record": {
   "as_of": "2026-11-06",
   "url": "https://mcp.ca-cm-kg.ai/record/TSXV/NTLX",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-08",
   "source": "https://iiroc.mediaroom.com/index.php?s=2429&l=100",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:e2daa5d6f3c68554d2eb42f97de788c4de3d6c05ff2f063cf7ca49048816677b",
 "path": "/ca/TSXV/NTLX",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "NeuroThera Labs Inc. is listed on the TSXV under ticker NTLX. The ISIN is not on the record; the LEI is 529900GPL3C0DVADMS32. The security type is Corporate, the sector is Life Sciences, and the jurisdiction is British Columbia (CA-BC). The segment is not on the record. The listing status is listed, not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 23 filings in the twelve months to 2026-11-06, across 20 filing days. Of these, 20 are newswire releases, 2 are exchange bulletins and 1 is a corporate action. The median gap between filing days is 13 days, against a TSXV median of 19 days and a Life Sciences median of 17.5 days. Days from the latest filing to the record date are 15, against a TSXV median of 17.0 days and a Life Sciences median of 14 days. The latest filing is a newswire release dated 2026-10-22. The TSXV median filings count is 9 and the Life Sciences median is 7.0.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor is not on the record; none was found. The auditor's location is not on the record, and the record holds no auditor changes.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "The record holds two name changes, dated 2025-10-23 and 2026-08-31. It holds no listing, delisting, domicile change or segment move lines. The halt flag is listed, not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "Under the acm-68000/ca/kyp-know-your-product-ni-31-103/r1 rule version, the outcome is determinable for both client categories: paragraph (o) of the definition and paragraph (q) of the definition, each with signal ACM-200. The chapter is as of 2026-11-04.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "No research houses were found on the issuer's investor-relations pages read; the count is 0.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "No openly published research notes were found; the count is 0.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The vintage is not sealed, and no issuer years are sealed. The market's earliest sealed date is not on the record. The live record began on 2026-09-10. Years 2021 through 2026 are sealed in the store but are not served as of a date; the as-of door answers not_sealed.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "7 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://www.tsx.com/json/company-directory/search/tsxv/^*"
  },
  {
   "for": "identity.jurisdiction",
   "source": "https://api.gleif.org/api/v1/lei-records/529900GPL3C0DVADMS32"
  },
  {
   "for": "identity.sector",
   "source": "https://www.tsx.com/en/resource/571"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.ca-cm-kg.ai/events/TSXV/NTLX"
  },
  {
   "for": "the halt flag",
   "source": "https://iiroc.mediaroom.com/index.php?s=2429&l=100"
  },
  {
   "for": "the orderability chapter",
   "source": "https://mcp.ca-cm-kg.ai/book/aio.json"
  },
  {
   "for": "the record",
   "source": "https://mcp.ca-cm-kg.ai/record/TSXV/NTLX"
  }
 ],
 "title": "NeuroThera Labs Inc. (NTLX) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}